Summit, New Jersey-based Kenvue Inc. (KVUE) is a consumer health company that develops, manufactures, and markets a broad portfolio of over-the-counter medicines, skincare products, oral care items, and self-care solutions. Valued at a market cap of $35.4 billion, the company’s portfolio includes well-known brands such as Tylenol, Listerine, Neutrogena, Aveeno, and Band-Aid, providing it with a strong presence in everyday healthcare and wellness.
Companies worth $10 billion or more are typically classified as “large-cap stocks,” and Kenvue fits the label perfectly, with its market cap exceeding this threshold, underscoring its size, influence, and dominance within the household & personal products industry. The company’s strength lies in its portfolio of iconic, trusted consumer health brands that enjoy strong brand loyalty and global recognition. Its specialty is in addressing everyday health and wellness needs, supported by decades of consumer trust and innovation.
